Publication | Closed Access

Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer

Medicinal ChemistryPolymer-drug ConjugateMedicineBronchial NeoplasmTumor TargetingPurine AmideAnti-cancer AgentStructure-guided DevelopmentPharmacologyRadiation OncologyLung CancerDrug Discovery